Table 2

Independent relationships between functional indices and the major determinants of functional impairment on inspiratory and expiratory CT, generated using stepwise regression

Extent of bronchiectasis (log) Bronchial wall dilatation (log) Bronchial wall thickness (log) Decreased attenuation (exp) (log)
FEV1
R 2= 0.39
p = 0.04–50.4
(–99.9 to –0.8)
p<0.01
41.7
(10.6 to 72.7)
p<0.005
-34.6
(–57.8 to –11.5)
p<0.001–22.4
(–35.1 to –9.7)
FEV1/FVC (log)
R 2 = 0.26
p = 0.09–0.28
(–0.62 to 0.05)
p<0.01
0.29
(0.08 to 0.50)
p<0.005–0.23
(–0.38 to –0.07)
p = 0.02–0.10
(–0.19 to –0.02)
RV (log)
R 2 = 0.37
p = 0.02
1.17
(0.21 to 2.14)
p<0.01–0.80
(–1.40 to –0.21)
p<0.01
0.62
(0.15 to 1.09)
p<0.01
0.35
(0.09 to 0.60)
Tlco
R 2= 0.18
p<0.01–26.1
(–44.5 to –7.8)
p = 0.15–7.8
(–18.3 to 2.80)
Kco
R 2 = 0.08
p<0.01–59.6
(–102.6 to 16.5)
p = 0.03
26.6
(3.0 to 50.2)
  • FEV1 = forced expiratory volume in one second; FVC = forced vital capacity; RV = residual volume; Tlco = carbon monoxide transfer factor; Kco = carbon monoxide transfer coefficient.

  • Equation R 2 values, p values and regression coefficients (95% confidence intervals in parentheses) are shown: abnormally distributed CT scores and lung function indices were transformed logarithmically to correct skewness. For example, percentage predicted FEV1 was negatively related to the extent of bronchiectasis (p = 0.04), the severity of bronchial wall thickening (p<0.005), and the extent of decreased attenuation on expiratory CT scan (p<0.001) and was positively related to the severity of bronchial dilatation (p<0.01). EquationR 2 (explaining variation in FEV1 levels) = 0.39.